de la Fuente, J., Gluckman, E., Makani, J., Telfer, P., Faulkner, L., Corbacioglu, S., , , Amrolia, P., Ansari, M., Balduzzi, A., Dalassier, A., Dalle, J., Hereda Diaz, C., Feuchtinger, T., Locatelli, F., Lucchini, G., Galimard, J., Gonzalez Vincent, M., Handgretinger, R., Kleinschmidt, K., Lawitschka, A., Perez Martinez, A., Peters, C., Rocha, V., Ruggeri, A., Sedlacek, P., Svec, P., Toporski, J., & Yesilipek, A. (2020). the role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing. Lancet, 7(12), e902–e911. http://access.bl.uk/ark:/81055/vdc_100114897732.0x000009